Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2002 R21 PAR-99-100 MAYER, BRUCE J UNIVERSITY OF CONNECTICUT SCH OF MED/DNT PROFILING TUMOR CELLS BY SH2 DOMAIN BINDING PATTERN Complete
2005 R21 RFA-CA-05-003 TUNG, CHING-HSUAN MASSACHUSETTS GENERAL HOSPITAL IMAGING TUMOR ASSOCIATED FIBROBLAST ACTIVATION PROTEIN Complete
2008 R21 RFA-CA-07-035 MCCAWLEY, LISA JOY VANDERBILT UNIVERSITY PARALLEL CAPILLARY BIOREACTORS FOR LEUKOCYTE TRANSENDOTHELIAL MIGRATION ANALYSIS Complete
2011 R21 RFA-CA-10-005 PARKER, LAURIE L. PURDUE UNIVERSITY LABEL-FREE, REAL-TIME DETECTION OF KINASE ACTIVITY IN VITRO AND IN SINGLE CELLS U Complete
2015 R21 RFA-CA-14-003 SARAF, RAVI F UNIVERSITY OF NEBRASKA LINCOLN HIGH SPECIFICITY MICRORNA MICROARRAY ANALYSIS WITHOUT PCR FOR CANCER SCREENING AND RESEARCH Complete
2018 R33 RFA-CA-17-011 JIANG, NING UNIVERSITY OF TEXAS, AUSTIN An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer Complete
1999 R41 PAR-98-066 MACH, ROBERT H ANASAZI BIOMEDICAL RESEARCH, INC. SIGMA 1 RECEPTOR PROBES FOR IMAGING TUMOR PROLIFERATION Complete
2001 R41 PAR-99-101 SULK, ROBERTA A DELTANU, LLC ONE STEP H. PYLORI TEST--SCREENING AND INDIVIDUAL ASSAYS Complete
2004 R33 PAR-01-106 ZANGAR, RICHARD C BATTELLE PACIFIC NORTHWEST LABORATORIES PROTEOMIC IDENTIFICATION OF NAF BIOMARKERS Complete
2007 R33 RFA-CA-07-001 ROTHSTEIN, RODNEY J. COLUMBIA UNIVERSITY HEALTH SCIENCES USING SYNTHETIC DOSAGE LETHALITY TO SCREEN FOR NOVEL ANTI-TUMOR TARGETS Complete
2010 R21 RFA-CA-09-008 KASSIS, AMIN I HARVARD MEDICAL SCHOOL NOVEL BLOOD ASSAY FOR LUNG CANCER DETECTION Complete
2007 R33 RFA-CA-07-001 BERTICS, PAUL JOHN UNIVERSITY OF WISCONSIN-MADISON MOLECULAR ANALYSIS USING LIQUID CRYSTAL TECHNOLOGY Complete
2010 R21 RFA-CA-09-008 SZMACINSKI, HENRYK UNIVERSITY OF MARYLAND BALTIMORE METHOD FOR DETECTION OF SECRETED PROTEINS IN SINGLE CELL ASSAYS Complete
2014 R33 RFA-CA-13-002 WEISS, WILLIAM A UNIVERSITY OF CALIFORNIA, SAN FRANCISCO INTEGRATING MASS CYTOMETRIC AND TRANSCRIPTOMIC PROFILES OF SOLID TUMORS Complete
2017 R33 RFA-CA-16-004 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA Rapid unbiased isolation and in situ RNA analysis of circulating tumor cells using a magnetic micropore-based diagnostic chip Complete
2001 R21 PAR-99-102 SPEICHER, DAVID W. WISTAR INSTITUTE NOVEL COMPREHENSIVE PROTEOME ANALYSES OF METASTASIS Complete
2003 R33 PAR-01-104 LAM, KIT S UNIVERSITY OF CALIFORNIA DAVIS SMALL MOLECULE MICROARRAYS FOR INTRACELLULAR PROTEINS Complete
2007 R21 RFA-CA-07-001 HUANG, FAQING UNIVERSITY OF SOUTHERN MISSISSIPPI FOLATE RECEPTOR-MEDIATED SIRNA DELIVERY TO CANCER CELLS Complete
2009 R21 RFA-CA-08-009 FOWLER, CAROL B AMERICAN REGISTRY OF PATHOLOGY, INC. RECOVERY OF PROTEINS FROM FORMALIN-FIXED TISSUES UNDER HIGH HYDROSTATIC PRESSURE Complete
2013 R33 RFA-CA-12-003 KAMM, ROGER D. MASSACHUSETTS INSTITUTE OF TECHNOLOGY MICROFLUIDIC 3D ASSAYS FOR METASTATIC CANCER Complete
2016 R43 PAR-13-327 GUNDERSON, KEVIN L ENCODIA, INC. Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer Complete
2000 R33 PAR-99-100 CONTAG, CHRISTOPHER H STANFORD UNIVERSITY VISIBLE ANIMAL MODELS OF NEOPLASTIC DISEASE Complete
2002 R43 PAR-99-101 HENKENS, ROBERT W ALDERON BIOSCIENCES, INC. INNOVATIVE TECHNOLOGY FOR GENE EXPRESSION STUDIES Complete
2006 R21 RFA-CA-06-003 FRANKENBURG, SHOSHANA HADASSAH-HEBREW UNIVERSITY MEDICAL CTR TARGETED ANTIGEN DELIVERY FOR CANCER IMMUNOTHERAPY Complete
2008 R44 RFA-CA-07-008 DOLINGER, DAVID LEE IQUUM, INC. RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS Complete
2012 R21 RFA-CA-12-002 DAVALOS, RAFAEL VIDAL VIRGINIA POLYTECHNIC INST AND ST UNIV ISOLATION OF TUMOR INITIATING CELLS (TICS) USING CONTACTLESS DIELECTROPHORESIS Complete
2015 R43 PAR-13-327 GAU, VINCENT JEN-JR GENEFLUIDICS, INC. PROMOTE HPV SCREENING RATE WITH A NON-INVASIVE HPV POC CARTRIDGE Complete
2019 R21 RFA-CA-18-002 O'NEILL, RACHEL UNIVERSITY OF CONNECTICUT STORRS Development and Utilization of Splice-specific Antibodies Complete
2000 R21 PAR-99-100 HERLYN, DOROTHEE M WISTAR INSTITUTE MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS Complete
2002 R21 PAR-99-100 CLEVELAND, WILLIAM L ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS ROBOTIC PREPARATION OF CDNA SINGLE CELLS Complete
2005 R21 RFA-CA-05-003 HYSLOP, TERRY THOMAS JEFFERSON UNIVERSITY NONLINEAR MODELS OF MRNA EXPRESSION IN CANCER BY RT-PCR Complete
2008 R21 RFA-CA-07-035 NELSON, EDWARD L UNIVERSITY OF CALIFORNIA-IRVINE APPLICATION OF A NOVEL NANOTECHNOLOGY FOR MOLECULAR PROFILING OF TUMOR CELLULAR E Complete
2011 R21 RFA-CA-10-005 MCDONALD, JOHN F GEORGIA INSTITUTE OF TECHNOLOGY USE OF NANOGELS TO TARGET DELIVERY OF SIRNA TO CANCER CELLS IN MICE Complete
2015 R21 RFA-CA-14-003 VO-DINH, TUAN DUKE UNIVERSITY NANOPLASMONICS-BASED MOLECULAR ANALYSIS TOOL FOR MOLECULAR BIOMARKERS OF CANCER Complete
2018 R33 RFA-CA-17-011 KONRY, TANIA TALI NORTHEASTERN UNIVERSITY Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform Complete
1999 R43 PAR-98-066 MOSTERT, MICHAEL J ECHELON BIOSCIENCES, INC. PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS Complete
2001 R43 PAR-99-101 PICCOLI, STEVEN P MOLECULAR STAGING, INC. ROLLING CIRCLE AMPLIFICATION ANALYSIS OF CERVICAL CELLS Complete
2004 R33 PAR-01-106 SINGER, ROBERT H ALBERT EINSTEIN COL OF MED YESHIVA UNIV FISH AND CHIPS: SINGLE CELL EXPRESSION OF CANCER GENES Complete
2004 R42 PAR-01-105 SKIPPER, PAUL L NEWTON SCIENTIFIC, INC. TRITUM AMS ANALYSIS OF CANCER BIOMARKERS Complete
2007 R33 RFA-CA-07-001 LIU, EDISON TAK-BUN GENOME INSTITUTE OF SINGAPORE PAIR-END-DITAG TECHNOLOGIES FOR THE COMPLETE ANNOTATION OF FUSION GENES Complete
2010 R21 RFA-CA-09-008 LIU, GUODONG NORTH DAKOTA STATE UNIVERSITY DEVELOPMENT OF A HAND-HELD CANCER BIOMARKER MONITOR Complete
2014 R33 RFA-CA-13-002 ROBINSON, WILLIAM H STANFORD UNIVERSITY LARGE-SCALE CHARACTERIZATION OF ANTI-CANCER ANTIBODY RESPONSES IN LUNG ADENOCARCI Complete
2017 R33 RFA-CA-16-004 PATTENDEN, SAMANTHA GAIL UNIV OF NORTH CAROLINA CHAPEL HILL The application of Enhanced Cavitation to enable DNA and Chromatin Extraction from Archived Tissues Complete
2021 R44 PAR-18-303 HUNG, PAUL JU-SUNG COMBINATI, INC. Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring Complete
2001 R21 PAR-99-102 ZHOU, PENGBO WEILL MEDICAL COLLEGE OF CORNELL UNIV PROTEIN KNOCKOUT TECHNOLOGY/MOLECULAR ANALYSIS OF CANCER Complete
2003 R33 PAR-01-106 FURGE, KYLE A VAN ANDEL RESEARCH INSTITUTE COMPARATIVE GENOMIC ANALYSIS OF MICROARRAY DATA Complete
2007 R21 RFA-CA-07-001 DING, ZHIYONG UT MD ANDERSON CANCER CTR EFFECTIVE MAMMALIAN TWO HYBRID SCREENING APPROACH Complete
2009 R33 RFA-CA-08-008 BEEBE, DAVID J UNIVERSITY OF WISCONSIN-MADISON MICROCHANNEL CELL-BASED ASSAYS TO ENABLE CANCER RESEARCH Complete
2013 R33 RFA-CA-12-003 FURDUI, CRISTINA MARIA WAKE FOREST UNIVERSITY HEALTH SCIENCES NEW REAGENTS FOR TRACKING PROTEIN OXIDATION IN CELLS BY MS AND IMAGING METHODS Complete
2016 R43 PAR-13-327 LIM, MARK AMBERGEN, INC Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays Complete

Pages